Latest News and Press Releases
Want to stay updated on the latest news?
-
Hyderabad, March 10, 2026 (GLOBE NEWSWIRE) -- The global molecular diagnostics market is witnessing significant expansion as healthcare systems increasingly adopt advanced diagnostic technologies to...
-
Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Viral Vaccine Cell Culture Media Market Size, Trends and Insights By Cell...
-
Austin, TX, USA, March 10, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Intravenous Infusion Pump Market Size, Trends and Insights By Product Type...
-
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) reduced the risk of disease progression or death versus...
-
mRNA vaccines do not just cause cells to produce antigen to spur immunity but affect many cellular pathways that change gene expression
-
Cytek Biosciences celebrates one year of operations at its Singapore facility, which has enhanced Cytek’s manufacturing capacity and regional service.
-
此次合作依托Tenacia在中枢神经系统(CNS)药物开发与商业化方面的专长,加速RAP-219在美国及全球的开发进程 Tenacia获得大中华区RAP-219开发和商业化的独家权利,针对病症包括局灶性发作癫痫和双相躁狂等适应症 Rapport将获得2000万美元的现金预付款,最高可达3.08亿美元的潜在开发与商业化里程碑款项及其他付款,以及个位数中段到十几中段的分级特许权使用费 ...
-
– The FDA assigned a PDUFA target action date of December 22, 2026 – – The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction...
-
Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million, driven by growth in MIPLYFFA® net revenue to $87.4 million 2025 EPS of $1.40...
-
WALTHAM, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet...